Companies To Watch
The Companies to Watch column spotlights small, entrepreneurial biopharma companies that are developing their own products (not just a platform) with little or no press coverage to date, and offering an interesting story involving useful business lessons.
-
Companies To Watch: Orca Bio
Orca Bio is creating a new cell therapy aimed at bringing rebirth to stem-cell transplantation.
-
Companies To Watch: Sonoma Biotherapeutics
Sonoma Biotherapeutics is bioengineering T cells to create potential cures for autoimmune and inflammatory conditions.
-
Companies To Watch: KaliVir Immunotherapeutics
KaliVir Immunotherapeutics is engineering oncolytic viruses with novel transgenes, and joining them to other immunotherapies, to defeat cancer and cancer relapse.
-
Companies To Watch: Hummingbird Bioscience
Hummingbird Bioscience is joining the forces of computational and systems biology to fight cancer and autoimmune disease.
-
Companies To Watch: Corner Therapeutics
Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.
-
Companies To Watch: Ocelot Bio
Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.
-
Companies To Watch: iTolerance
iTolerance is dedicated to curing diabetes and other conditions by inducing local immune tolerance in implantation.
-
Companies To Watch: CytoAgents
CytoAgents is combatting the broad areas of disease stemming from a common cause: cytokine release syndrome.
-
Companies To Watch: Viking Therapeutics
Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.
-
Companies To Watch: Priothera
Priothera is bent on boosting the safety and effectiveness of hematopoietic stem cell transplantation for blood cancers.
-
Companies To Watch: Mirum Pharmaceuticals
Mirum Pharmaceuticals: Two drugs, one FDA approved, together taking on a half-dozen rare liver diseases.
-
Companies To Watch: CinCor Pharma
CinCor Pharma is uncovering a great potential for combatting treatment-resistant and uncontrolled hypertension.
-
Companies To Watch: Castle Creek Biosciences
For Castle Creek Biosciences, there are many stakes at play in targeting rare skin, connective tissue, liver, and metabolic disorders.
-
Companies To Watch: Global Blood Therapeutics
Global Blood Therapeutics is intertwining science, business, and social missions to make progress against sickle cell disease.
IN THIS MONTH'S ISSUE
BEYOND THE PRINTED PAGE
-
2023 Manufacturing And Supply Chain Outlook: Additional Insights12/16/2022
Additional executive responses to our 2023 manufacturing and supply chain outlook questions.
-
2023 Finance And Funding Outlook: Additional Insights Part 212/9/2022
Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.
-
2023 Finance And Funding Outlook: Additional Insights Part 112/2/2022
Biopharma executives offer options, tips and strategies for navigating finance and funding challenges in 2023.